Cargando…
The Incremental Prognostic Value of Baseline (18)F-FDG PET/CT Imaging in Angioimmunoblastic T-Cell Lymphoma
METHODS: From January 2010 to October 2019, a total of 23 patients who pathologically confirmed to have AITL were retrospectively analyzed. All patients underwent whole-body (18)F-FDG PET/CT scan before chemotherapy. The (18)F-FDG PET/CT features, clinical data, laboratory indicators, Ki67 labeling...
Autores principales: | Wang, Hui, Yu, Wenjing, Wu, Tao, Xue, Yangyang, Zhang, Dan, Xu, Huiqin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298254/ https://www.ncbi.nlm.nih.gov/pubmed/32596312 http://dx.doi.org/10.1155/2020/4502489 |
Ejemplares similares
-
Prognostic value of baseline total metabolic tumour volume of (18)F-FDG PET/CT imaging in patients with angioimmunoblastic T-cell lymphoma
por: Gong, Huanyu, et al.
Publicado: (2021) -
Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020) -
Prognostic values of baseline, interim and end-of therapy (18)F-FDG PET/CT in patients with follicular lymphoma
por: Zhou, Yeye, et al.
Publicado: (2019) -
Prognostic Value of Heterogeneity Index Derived from Baseline (18)F-FDG PET/CT in Mantle Cell Lymphoma
por: Liu, Fei, et al.
Publicado: (2022) -
The added prognostic values of baseline PET dissemination parameter in patients with angioimmunoblastic T‐cell lymphoma
por: Gong, Huanyu, et al.
Publicado: (2022)